Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy protection, with plans to continue operations as it works out a plan to pay its debts. The company, which ...
The AI-driven platform identifies cell cycle deregulation and tumor immune microenvironment dynamics from biopsy images.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback